Monday, May 04, 2020 1:25:23 PM
From my standpoint, it seems like Arrayit is trying to capitalize on the crisis (and I don't blame them assuming their test is legit) but it would be a real shame if they rushed into the COVID market before they were ready. Not only would they get a bigger black eye if the FDA pulls their testing from the market but will just add insult to injury (the suspension).
If, and it's a big IF, their allergy testing is expanding and gaining acceptance as it seems to be, then it would be terrible if they jeopardized all of that for the sake of chasing the pot of gold at the end of the COVID rainbow.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM